Cardiovascular complications of multiple myeloma in the elderly

P Mathur, S Thanendrarajan, H Paydak… - Expert Review of …, 2017 - Taylor & Francis
Introduction: Multiple myeloma is a malignant neoplasm characterized by plasma cell
proliferation in blood and bone marrow. Approximately two-thirds of the patients with …

Evidence-based guidelines for preventing and managing side effects of multiple myeloma

P Bertolotti, A Pierre, S Rome, B Faiman - Seminars in Oncology Nursing, 2017 - Elsevier
Objective To review disease-related symptoms and side effects of treatment in patients with
multiple myeloma (MM). Data Sources Peer-reviewed articles, research studies, and clinical …

[PDF][PDF] Kardiovaskulárne komplikácie vyvolané liečbou hematologických malignít

MUDB Mladosievičová - solen.sk
Nové terapeutické postupy zlepšili kurabilitu hematologických malignít, ale často za cenu
neočakávaných nepriaznivých akútnych, chronických aj neskorých kardiovaskulárnych …

Możliwości leczenia indukcyjnego chorych na szpiczaka plazmocytowego kwalifikujących się do chemioterapii wysokodawkowanej wspomaganej autologiczną …

A Druzd-Sitek, J Walewski - Acta Haematologica Polonica, 2017 - Elsevier
Despite significant progress in the treatment of multiple myeloma, it still remains an
incurable disease. The introduction of new drugs has contributed to the increased overall …

Different induction regimens for myeloma patients eligible for high-dose chemotherapy followed by autologous stem cell transplantations and Polish Myeloma Group …

A Druzd-Sitek, J Walewski - Acta Haematologica Polonica, 2017 - journals.viamedica.pl
Despite significant progress in the treatment of multiple myeloma, it still remains an
incurable disease. The introduction of new drugs has contributed to the increased overall …